LENSAR Stock Forecast, Price & News

LENSAR (NASDAQ:LNSR) Frequently Asked Questions

Is LENSAR a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LENSAR stock.
View analyst ratings for LENSAR or view top-rated stocks.

When is LENSAR's next earnings date?

LENSAR is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for LENSAR.

How were LENSAR's earnings last quarter?

LENSAR, Inc. (NASDAQ:LNSR) released its quarterly earnings results on Monday, November, 8th. The company reported ($0.65) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.06. The business had revenue of $8.27 million for the quarter, compared to analyst estimates of $7.67 million. LENSAR had a negative net margin of 71.47% and a negative trailing twelve-month return on equity of 36.01%. During the same period in the prior year, the company posted ($0.64) earnings per share.
View LENSAR's earnings history.

What price target have analysts set for LNSR?

2 equities research analysts have issued twelve-month price objectives for LENSAR's shares. Their forecasts range from $15.00 to $20.00. On average, they expect LENSAR's stock price to reach $17.50 in the next twelve months. This suggests a possible upside of 159.3% from the stock's current price.
View analysts' price targets for LENSAR or view top-rated stocks among Wall Street analysts.

Who are LENSAR's key executives?

LENSAR's management team includes the following people:

• Mr. Nicholas T. Curtis, CEO & Director (Age 65, Pay $748.46k)
• Mr. Thomas R. Staab II, Chief Financial Officer (Age 53, Pay $347.26k)
• Mr. Alan B. Connaughton, Chief Operating Officer (Age 49, Pay $519.52k)

Who are some of LENSAR's key competitors?

Some companies that are related to LENSAR include Retractable Technologies (RVP), Westaim (WEDXF), Lucid Diagnostics (LUCD), Co-Diagnostics (CODX), DarioHealth (DRIO), NeuroPace (NPCE), CVRx (CVRX), Apollo Endosurgery (APEN), Profound Medical (PROF), Liquidia (LQDA), Cytosorbents (CTSO), TransEnterix (TRXC), iCAD (ICAD), TELA Bio (TELA) and Repro Med Systems (KRMD).
View all of LNSR's competitors.

What is LENSAR's stock symbol?

LENSAR trades on the NASDAQ under the ticker symbol "LNSR."

Who are LENSAR's major shareholders?

LENSAR's stock is owned by a number of retail and institutional investors. Top institutional investors include Park West Asset Management LLC (9.59%), Dimensional Fund Advisors LP (6.22%), Madison Avenue Partners LP (6.17%), Renaissance Technologies LLC (3.38%), BlackRock Inc. (1.64%) and Millennium Management LLC (0.99%).

Which institutional investors are buying LENSAR stock?

LNSR stock was acquired by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, Dimensional Fund Advisors LP, Madison Avenue Partners LP, Renaissance Technologies LLC, BlackRock Inc., Millennium Management LLC, Connor Clark & Lunn Investment Management Ltd., and Geode Capital Management LLC.

How do I buy shares of LENSAR?

Shares of LNSR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LENSAR's stock price today?

One share of LNSR stock can currently be purchased for approximately $6.75.

How much money does LENSAR make?

LENSAR has a market capitalization of $73.96 million and generates $26.38 million in revenue each year. The company earns $-19.77 million in net income (profit) each year or ($2.46) on an earnings per share basis.

How many employees does LENSAR have?

LENSAR employs 35 workers across the globe.

What is LENSAR's official website?

The official website for LENSAR is www.lensar.com.

How can I contact LENSAR?

The company can be reached via phone at 888-536-7271 or via email at [email protected].